Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) | MicrobiomeTrials
Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-07-25Est. Completion: 2027-07-15
Enrollment target: 1 participants
Locations
Tennessee Oncology, PLLC, Nashville, Tennessee, United States
Pan American Center for Oncology Trials, LLC, San Juan, Puerto Rico
Other microbiome trials you might be interested in